Dr. Konecny on the Value of PARP Inhibitors in Ovarian Cancer
September 19th 2018Gottfried E. Konecny, MD, associate professor of medicine, University of California, Los Angeles, discusses studies that demonstrate the value of PARP inhibitors in the treatment of patients with ovarian cancer.
Read More